chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Severe headache; Muscle and body aches, general achiness; Joint aches; Tired; Chills; 101 Fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HEADACHE (Severe headache), MYALGIA (Muscle and body aches, general achiness), ARTHRALGIA (Joint aches), FATIGUE (Tired) and CHILLS (Chills) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MYCOPHENOLATE MOFETIL, METHOTREXATE SODIUM (METOTREXATE), APREMILAST and LEVOTHYROXINE for an unknown indication.    On 28-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (Chills) and PYREXIA (101 Fever). On an unknown date, the patient experienced HEADACHE (Severe headache), MYALGIA (Muscle and body aches, general achiness), ARTHRALGIA (Joint aches) and FATIGUE (Tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 31-Jan-2021, CHILLS (Chills) and PYREXIA (101 Fever) had resolved. At the time of the report, HEADACHE (Severe headache), MYALGIA (Muscle and body aches, general achiness), ARTHRALGIA (Joint aches) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 101 (High) 101 fever.. On 29-Jan-2021, Body temperature: 103 (High) 103 fever that lasted 24 hours. On 31-Jan-2021, Body temperature: 101-102 (High) fever, 101-102 until 31Jan2021..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 29-Jan-2021, at 3 AM the patient woke up with teeth chattering chills, she never experienced before and a 103 fever that lasted 24 hours. She continued with fever, 101-102 and chills until 31-Jan-2021.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Severe headache; Muscle and body aches, general achiness; Joint aches; Tired; Chills; 101 Fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HEADACHE (Severe headache), MYALGIA (Muscle and body aches, general achiness), ARTHRALGIA (Joint aches), FATIGUE (Tired) and CHILLS (Chills) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MYCOPHENOLATE MOFETIL, METHOTREXATE SODIUM (METOTREXATE), APREMILAST and LEVOTHYROXINE for an unknown indication.    On 28-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (Chills) and PYREXIA (101 Fever). On an unknown date, the patient experienced HEADACHE (Severe headache), MYALGIA (Muscle and body aches, general achiness), ARTHRALGIA (Joint aches) and FATIGUE (Tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 31-Jan-2021, CHILLS (Chills) and PYREXIA (101 Fever) had resolved. At the time of the report, HEADACHE (Severe headache), MYALGIA (Muscle and body aches, general achiness), ARTHRALGIA (Joint aches) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 101 (High) 101 fever.. On 29-Jan-2021, Body temperature: 103 (High) 103 fever that lasted 24 hours. On 31-Jan-2021, Body temperature: 101-102 (High) fever, 101-102 until 31Jan2021..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 29-Jan-2021, at 3 AM the patient woke up with teeth chattering chills, she never experienced before and a 103 fever that lasted 24 hours. She continued with fever, 101-102 and chills until 31-Jan-2021.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: soreness at injection site; itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE PRURITUS (itching at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE PRURITUS (itching at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE PRURITUS (itching at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Fatigue, Lethargy, Malaise, Vaccination site erythema
Clinical narrative: Lethargic; Not feeling well; symptoms are worse; tired; itching; swelling at injection site; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), MALAISE (Not feeling well), CONDITION AGGRAVATED (symptoms are worse), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE ERYTHEMA (injection site redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE PRURITUS (itching). On 01-Feb-2021, the patient experienced LETHARGY (Lethargic), MALAISE (Not feeling well), CONDITION AGGRAVATED (symptoms are worse) and FATIGUE (tired). At the time of the report, LETHARGY (Lethargic), MALAISE (Not feeling well), CONDITION AGGRAVATED (symptoms are worse), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (injection site redness), FATIGUE (tired) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included blood pressure medication, antioxidants and losartan.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Lethargic; Not feeling well; symptoms are worse; tired; itching; swelling at injection site; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), MALAISE (Not feeling well), CONDITION AGGRAVATED (symptoms are worse), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE ERYTHEMA (injection site redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE PRURITUS (itching). On 01-Feb-2021, the patient experienced LETHARGY (Lethargic), MALAISE (Not feeling well), CONDITION AGGRAVATED (symptoms are worse) and FATIGUE (tired). At the time of the report, LETHARGY (Lethargic), MALAISE (Not feeling well), CONDITION AGGRAVATED (symptoms are worse), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (injection site redness), FATIGUE (tired) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included blood pressure medication, antioxidants and losartan.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: swelled up; really hard; Tender; Itching; Really chilly; Red spot at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot at injection site), VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender) and VACCINATION SITE PRURITUS (Itching) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot at injection site). On 28-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender), VACCINATION SITE PRURITUS (Itching) and CHILLS (Really chilly). At the time of the report, VACCINATION SITE ERYTHEMA (Red spot at injection site), VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender), VACCINATION SITE PRURITUS (Itching) and CHILLS (Really chilly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment or concomitant medications were reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelled up; really hard; Tender; Itching; Really chilly; Red spot at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot at injection site), VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender) and VACCINATION SITE PRURITUS (Itching) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot at injection site). On 28-Jan-2021, the patient experienced VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender), VACCINATION SITE PRURITUS (Itching) and CHILLS (Really chilly). At the time of the report, VACCINATION SITE ERYTHEMA (Red spot at injection site), VACCINATION SITE SWELLING (swelled up), VACCINATION SITE REACTION (really hard), VACCINATION SITE PAIN (Tender), VACCINATION SITE PRURITUS (Itching) and CHILLS (Really chilly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment or concomitant medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pruritus
Clinical narrative: Left arm started to itching; A red spot the size of a silver dollar and it was 4 inches below the injection site;  This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Jan-2021 and was forwarded to Moderna on 02-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm started to itching) and INJECTION SITE ERYTHEMA (A red spot the size of a silver dollar and it was 4 inches below the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PRURITUS (Left arm started to itching) and INJECTION SITE ERYTHEMA (A red spot the size of a silver dollar and it was 4 inches below the injection site). At the time of the report, PRURITUS (Left arm started to itching) had not resolved and INJECTION SITE ERYTHEMA (A red spot the size of a silver dollar and it was 4 inches below the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: DRY COUGH; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (DRY COUGH) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis and Blood pressure.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced COUGH (DRY COUGH). On 31-Jan-2021, COUGH (DRY COUGH) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concurrent medications included medication for treating arthritis and blood pressure. Treatment medication was not reported.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial flutter, Heart rate increased, Pruritus
Clinical narrative: Atrial Flutter diagnosis; Increased heart rate; Itchy warm arm; A spontaneous report was received from a consumer concerning a 93-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced atrial flutter diagnosis, itchy warm arm, increased heart rate.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 19 Jan 2021, 8 days after the vaccination, the patient's arm started to feel itchy and warm, also had an increased heart rate. The patient went to a Cardiologist and diagnosed with Atrial Flutter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events were unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Oral herpes
Clinical narrative: swollen lymp nodes in neck; Cold sores on lips; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold sores on lips) and LYMPHADENOPATHY (swollen lymp nodes in neck) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M204) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 30-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 30-Jan-2021, the patient experienced ORAL HERPES (Cold sores on lips). On 01-Feb-2021, the patient experienced LYMPHADENOPATHY (swollen lymp nodes in neck). At the time of the report, ORAL HERPES (Cold sores on lips) and LYMPHADENOPATHY (swollen lymp nodes in neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment medication was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Nasal congestion
Clinical narrative: Cough; A little congestion in my throat; My head was stopped up a little bit; A spontaneous report was received from a consumer concerning himself a 73-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events cough, a little congestion in his throat/nasal congestion, his head was stopped up a little bit/headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 19 Jan 2021, the patient experienced the event(s) cough. a little congestion in his throat, his head was stopped up a little bit.  Treatment details included natural herb cough drops.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s) cough, congestion in throat and his head was stopped up a little bit were resolved on 27 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nasopharyngitis, Swollen tongue
Clinical narrative: felt real cold; tongue was swelling a bit; 2 bouts of diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (felt real cold), SWOLLEN TONGUE (tongue was swelling a bit) and DIARRHOEA (2 bouts of diarrhea) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced NASOPHARYNGITIS (felt real cold), SWOLLEN TONGUE (tongue was swelling a bit) and DIARRHOEA (2 bouts of diarrhea). On 10-Jan-2021, NASOPHARYNGITIS (felt real cold), SWOLLEN TONGUE (tongue was swelling a bit) and DIARRHOEA (2 bouts of diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported but it was mentioned that patient was under concomitant medications. Patient had Drank ice cold water which made her feel better. Patient reports diarrhea could be due to her eating habits.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: Itching at the injection site; Hives all around it; Pain at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE URTICARIA (Hives all around it), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE URTICARIA (Hives all around it), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE URTICARIA (Hives all around it), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (High blood pressure).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test: other (Positive) Tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication including  blood pressure medication was reported  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Dry skin, Erythema
Clinical narrative: Joint pain on her shoulder  it was painful to raise the arm  different side from the injection site.; Burning unbearably on hand; her hand was dry; Little redness on thumb, redness from wrist to knuckles; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Little redness on thumb, redness from wrist to knuckles), BURNING SENSATION (Burning unbearably on hand), DRY SKIN (her hand was dry) and ARTHRALGIA (Joint pain on her shoulder  it was painful to raise the arm  different side from the injection site.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder, Interstitial pneumonitis, Paroxysmal atrial fibrillation, Alopecia, Rosacea and GERD. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), PREDNISONE, MYCOPHENOLIC ACID, METOPROLOL, SPIRONOLACTONE, SILDENAFIL, EZETIMIBE, SULFAMETHOXAZOLE, CYANOCOBALAMIN (VIT B12), MONASCUS PURPUREUS (RED YEAST RICE), UBIDECARENONE (CO Q10) and IRON for an unknown indication, ALPRAZOLAM, RITUXIMAB and VITAMIN D NOS.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ERYTHEMA (Little redness on thumb, redness from wrist to knuckles). On 30-Jan-2021, the patient experienced DRY SKIN (her hand was dry). On 31-Jan-2021, the patient experienced BURNING SENSATION (Burning unbearably on hand). On 01-Feb-2021, the patient experienced ARTHRALGIA (Joint pain on her shoulder  it was painful to raise the arm  different side from the injection site.). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Little redness on thumb, redness from wrist to knuckles) and BURNING SENSATION (Burning unbearably on hand) was resolving, DRY SKIN (her hand was dry) had not resolved and ARTHRALGIA (Joint pain on her shoulder  it was painful to raise the arm  different side from the injection site.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       30Jan2021 her hand was dry, and she put a little cream on it.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema, Vaccination site inflammation, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: I scratched my arm and it was inflamed; I felt I had been beaten by a bee; I scratched my arm and it was hot; itching went away; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (I scratched my arm and it was inflamed ), PAIN (I felt I had been beaten by a bee), VACCINATION SITE WARMTH (I scratched my arm and it was hot), VACCINATION SITE PRURITUS (itching went away) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 032L20A) for COVID-19 vaccination.     Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE INFLAMMATION (I scratched my arm and it was inflamed ), PAIN (I felt I had been beaten by a bee), VACCINATION SITE WARMTH (I scratched my arm and it was hot), VACCINATION SITE PRURITUS (itching went away) and VACCINATION SITE ERYTHEMA (Redness at the injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 28-Jan-2021, VACCINATION SITE PRURITUS (itching went away) had resolved. At the time of the report, VACCINATION SITE INFLAMMATION (I scratched my arm and it was inflamed ), PAIN (I felt I had been beaten by a bee) and VACCINATION SITE WARMTH (I scratched my arm and it was hot) was resolving and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Advill, ice and then cortisone cream.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye irritation, Fatigue, Myalgia, Nasal congestion
Clinical narrative: nasal congestion; burning sensation in eye; sore throat; chills; body ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion), EYE IRRITATION (burning sensation in eye), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and MYALGIA (body ache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (chills), MYALGIA (body ache) and FATIGUE (fatigue). On 31-Jan-2021, the patient experienced NASAL CONGESTION (nasal congestion), EYE IRRITATION (burning sensation in eye) and OROPHARYNGEAL PAIN (sore throat). On 31-Jan-2021, CHILLS (chills), MYALGIA (body ache) and FATIGUE (fatigue) had resolved. At the time of the report, NASAL CONGESTION (nasal congestion), EYE IRRITATION (burning sensation in eye) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.            Treatment details included Steroid Eye Drops.  Concomitant medication was not provided by reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: nasal congestion; burning sensation in eye; sore throat; chills; body ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion), EYE IRRITATION (burning sensation in eye), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and MYALGIA (body ache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (chills), MYALGIA (body ache) and FATIGUE (fatigue). On 31-Jan-2021, the patient experienced NASAL CONGESTION (nasal congestion), EYE IRRITATION (burning sensation in eye) and OROPHARYNGEAL PAIN (sore throat). On 31-Jan-2021, CHILLS (chills), MYALGIA (body ache) and FATIGUE (fatigue) had resolved. At the time of the report, NASAL CONGESTION (nasal congestion), EYE IRRITATION (burning sensation in eye) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.            Treatment details included Steroid Eye Drops.  Concomitant medication was not provided by reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test positive, SARS-CoV-2 test
Clinical narrative: test came back positive (for Covid-19); This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST POSITIVE (test came back positive (for Covid-19)) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included TRAZODONE for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced SARS-COV-2 ANTIBODY TEST POSITIVE (test came back positive (for Covid-19)). At the time of the report, SARS-COV-2 ANTIBODY TEST POSITIVE (test came back positive (for Covid-19)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test (positive-negative): positive (Positive) On 28Jan2021 test came back positive..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Bruise; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced CONTUSION (Bruise). At the time of the report, CONTUSION (Bruise) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: It is itching; Redness about the size of a pear at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (It is itching) and VACCINATION SITE ERYTHEMA (Redness about the size of a pear at the injection site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (It is itching) and VACCINATION SITE ERYTHEMA (Redness about the size of a pear at the injection site). At the time of the report, VACCINATION SITE PRURITUS (It is itching) and VACCINATION SITE ERYTHEMA (Redness about the size of a pear at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Body aches; Chills; Feverish; Muscle pain; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (Body aches), CHILLS (Chills), PYREXIA (Feverish) and MYALGIA (Muscle pain) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), MYALGIA (Body aches), CHILLS (Chills), PYREXIA (Feverish) and MYALGIA (Muscle pain). At the time of the report, PAIN IN EXTREMITY (Sore arm), MYALGIA (Body aches), CHILLS (Chills), PYREXIA (Feverish) and MYALGIA (Muscle pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: Experienced an adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Experienced an adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Experienced an adverse reaction). At the time of the report, ADVERSE DRUG REACTION (Experienced an adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Injection site was itchy; Injection site was red; Injection site was swollen; Injection site was little sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Injection site was itchy), INJECTION SITE ERYTHEMA (Injection site was red), INJECTION SITE SWELLING (Injection site was swollen) and INJECTION SITE PAIN (Injection site was little sore) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 127L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical conditions were reported).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Injection site was itchy), INJECTION SITE ERYTHEMA (Injection site was red), INJECTION SITE SWELLING (Injection site was swollen) and INJECTION SITE PAIN (Injection site was little sore). At the time of the report, INJECTION SITE PRURITUS (Injection site was itchy), INJECTION SITE ERYTHEMA (Injection site was red), INJECTION SITE SWELLING (Injection site was swollen) and INJECTION SITE PAIN (Injection site was little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough
Clinical narrative: coughing; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing) and ARTHRALGIA (Soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced ARTHRALGIA (Soreness). On 14-Jan-2021, the patient experienced COUGH (coughing). At the time of the report, COUGH (coughing) and ARTHRALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: exposed to a person who tested positive on Feb 1st; This spontaneous case was reported by a patient family member or friend and describes the occurrence of EXPOSURE TO SARS-COV-2 (exposed to a person who tested positive on Feb 1st) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced EXPOSURE TO SARS-COV-2 (exposed to a person who tested positive on Feb 1st). At the time of the report, EXPOSURE TO SARS-COV-2 (exposed to a person who tested positive on Feb 1st) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pain in extremity, Rash
Clinical narrative: they feel unomfortable towards neck; A rash on the arm ,it is blotched and red; SORE ARM; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), MUSCULOSKELETAL DISCOMFORT (they feel unomfortable towards neck) and RASH (A rash on the arm ,it is blotched and red) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (SORE ARM). On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (they feel unomfortable towards neck) and RASH (A rash on the arm ,it is blotched and red). On 22-Jan-2021, PAIN IN EXTREMITY (SORE ARM) had resolved. At the time of the report, MUSCULOSKELETAL DISCOMFORT (they feel unomfortable towards neck) and RASH (A rash on the arm ,it is blotched and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dizziness postural
Clinical narrative: Dizziness when laying prong and sits up; Lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS POSTURAL (Dizziness when laying prong and sits up) and DIZZINESS (Lightheaded) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced DIZZINESS POSTURAL (Dizziness when laying prong and sits up) and DIZZINESS (Lightheaded). At the time of the report, DIZZINESS POSTURAL (Dizziness when laying prong and sits up) and DIZZINESS (Lightheaded) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis
Clinical narrative: Every joint in her body aches. wrist, knees, ankles, hips, back, everything is just aching; She has arthritis but this is worse than it has ever been; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Every joint in her body aches. wrist, knees, ankles, hips, back, everything is just aching) and ARTHRITIS (She has arthritis but this is worse than it has ever been) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced ARTHRALGIA (Every joint in her body aches. wrist, knees, ankles, hips, back, everything is just aching) and ARTHRITIS (She has arthritis but this is worse than it has ever been). At the time of the report, ARTHRALGIA (Every joint in her body aches. wrist, knees, ankles, hips, back, everything is just aching) and ARTHRITIS (She has arthritis but this is worse than it has ever been) outcome was unknown. Not Provided          No relevant concomitant medications were reported  No treatment information was provided.; Reporter's Comments: The patient already had arthritis and it became worse after taking the vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Mobility decreased, Pain
Clinical narrative: Arm was heavy; She was in pain; Unable to move her arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm was heavy), PAIN (She was in pain) and MOBILITY DECREASED (Unable to move her arm) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced LIMB DISCOMFORT (Arm was heavy), PAIN (She was in pain) and MOBILITY DECREASED (Unable to move her arm). At the time of the report, LIMB DISCOMFORT (Arm was heavy), PAIN (She was in pain) and MOBILITY DECREASED (Unable to move her arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: my injection site was sore; cough; nasal drainage; tested positive for Covid-19; severe tiredness; no appetite; vomiting; diarrhea; fever of 100.3°F; chills; body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), FATIGUE (severe tiredness), DECREASED APPETITE (no appetite), VOMITING (vomiting) and DIARRHOEA (diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (severe tiredness), DECREASED APPETITE (no appetite), VOMITING (vomiting), DIARRHOEA (diarrhea), PYREXIA (fever of 100.3°F), CHILLS (chills), PAIN (body aches) and HEADACHE (headache). On 11-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). On 03-Feb-2021, the patient experienced INJECTION SITE PAIN (my injection site was sore), COUGH (cough) and RHINORRHOEA (nasal drainage). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), FATIGUE (severe tiredness), DECREASED APPETITE (no appetite), VOMITING (vomiting), DIARRHOEA (diarrhea), PYREXIA (fever of 100.3°F), CHILLS (chills), PAIN (body aches), HEADACHE (headache), INJECTION SITE PAIN (my injection site was sore), COUGH (cough) and RHINORRHOEA (nasal drainage) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  Treatment details included I took Tylenol for the headache   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: my injection site was sore; cough; nasal drainage; tested positive for Covid-19; severe tiredness; no appetite; vomiting; diarrhea; fever of 100.3°F; chills; body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), FATIGUE (severe tiredness), DECREASED APPETITE (no appetite), VOMITING (vomiting) and DIARRHOEA (diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FATIGUE (severe tiredness), DECREASED APPETITE (no appetite), VOMITING (vomiting), DIARRHOEA (diarrhea), PYREXIA (fever of 100.3°F), CHILLS (chills), PAIN (body aches) and HEADACHE (headache). On 11-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). On 03-Feb-2021, the patient experienced INJECTION SITE PAIN (my injection site was sore), COUGH (cough) and RHINORRHOEA (nasal drainage). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), FATIGUE (severe tiredness), DECREASED APPETITE (no appetite), VOMITING (vomiting), DIARRHOEA (diarrhea), PYREXIA (fever of 100.3°F), CHILLS (chills), PAIN (body aches), HEADACHE (headache), INJECTION SITE PAIN (my injection site was sore), COUGH (cough) and RHINORRHOEA (nasal drainage) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  Treatment details included I took Tylenol for the headache   Reporter did not allow further contact